Celcuity Inc. (CELC) - Cash on Hand per Share

Symbol and logo of brand Celcuity Therapeutics (CELC)

The laboratory and instrument outsourcing strategy of Celcuity Inc. (CELC) impacts the cash per share dynamics illustrated in this chart on GURU.Markets. The value 13.07 describes the current liquidity level supported by streamlined express delivery of biosamples. Financial stability is based on a unique live-cell testing platform, which allows the company to independently determine the pricing power of its oncology tests.

CELC - Celcuity Corp Cash per Share over the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Celcuity Inc (CELC)

- stock value and consensus price forecast:
- market capitalization indicators:
- cash and cash flow data:
General company analysis:Celcuity Inc., CELC
Core merchandise of Celcuity

This indicator is calculated by dividing the total volume of liquid assets by the total number of shares, determining the actual cash reserve per share to assess default resilience. By analyzing the cash per share metric, a Celcuity Inc. (CELC) investor can evaluate the company's ability to fund risky cancer therapy developments amid intense pressure from pharmaceutical behemoths.